Home > Income Statement > SUVEN PHARMACEUTICALS

SUVEN PHARMACEUTICALS
Revenue

    Back to Income Statement
SUVEN PHARMACEUTICALS is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
AD     Remove this Ad

SUVEN PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹1,051 Cr₹134,033 Cr₹1,320 Cr₹1,010 Cr₹834 Cr

What is the latest Revenue of SUVEN PHARMACEUTICALS ?

The latest Revenue ratio of SUVEN PHARMACEUTICALS is ₹1,051 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹1,051 Cr
Mar2024₹134,033 Cr
Mar2023₹1,320 Cr
Mar2022₹1,010 Cr
Mar2021₹834 Cr

How is Revenue of SUVEN PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹1,051 Cr
-99.22
Mar2024 ₹134,033 Cr
10,052.30
Mar2023 ₹1,320 Cr
30.75
Mar2022 ₹1,010 Cr
21.10
Mar2021 ₹834 Cr -

Compare Revenue of peers of SUVEN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS ₹11,686.5 Cr -0.2% -21% -71.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,753.0 Cr 1.5% 5.5% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,032.0 Cr 2.3% 3.6% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹143,426.0 Cr -0.5% 5.3% 40.2% Stock Analytics
CIPLA ₹108,360.0 Cr -1.1% -2.2% -8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,859.0 Cr 0.9% 5.2% 7% Stock Analytics


SUVEN PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
SUVEN PHARMACEUTICALS

-0.2%

-21%

-71.1%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses